SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-18-060776
Filing Date
2018-11-19
Accepted
2018-11-19 16:24:05
Documents
6
Period of Report
2018-12-18
Effectiveness Date
2018-11-19

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT tv506934-def14a.htm DEF 14A 916621
2 GRAPHIC lg_ibio.jpg GRAPHIC 34702
3 GRAPHIC sg_elizabeth-moyle.jpg GRAPHIC 23312
4 GRAPHIC sg_robert-kay.jpg GRAPHIC 26487
5 GRAPHIC tv506934_pc1.jpg GRAPHIC 366667
6 GRAPHIC tv506934_pc2.jpg GRAPHIC 396299
  Complete submission text file 0001144204-18-060776.txt   2085637
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-35023 | Film No.: 181192766
SIC: 2834 Pharmaceutical Preparations